Prediction of disease-free survival for precision medicine using cooperative learning on multi-omic data.


Journal

Briefings in bioinformatics
ISSN: 1477-4054
Titre abrégé: Brief Bioinform
Pays: England
ID NLM: 100912837

Informations de publication

Date de publication:
23 May 2024
Historique:
received: 17 10 2023
revised: 17 04 2024
accepted: 16 05 2024
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 5 6 2024
Statut: ppublish

Résumé

In precision medicine, both predicting the disease susceptibility of an individual and forecasting its disease-free survival are areas of key research. Besides the classical epidemiological predictor variables, data from multiple (omic) platforms are increasingly available. To integrate this wealth of information, we propose new methodology to combine both cooperative learning, a recent approach to leverage the predictive power of several datasets, and polygenic hazard score models. Polygenic hazard score models provide a practitioner with a more differentiated view of the predicted disease-free survival than the one given by merely a point estimate, for instance computed with a polygenic risk score. Our aim is to leverage the advantages of cooperative learning for the computation of polygenic hazard score models via Cox's proportional hazard model, thereby improving the prediction of the disease-free survival. In our experimental study, we apply our methodology to forecast the disease-free survival for Alzheimer's disease (AD) using three layers of data. One layer contains epidemiological variables such as sex, APOE (apolipoprotein E, a genetic risk factor for AD) status and 10 leading principal components. Another layer contains selected genomic loci, and the last layer contains methylation data for selected CpG sites. We demonstrate that the survival curves computed via cooperative learning yield an AUC of around $0.7$, above the state-of-the-art performance of its competitors. Importantly, the proposed methodology returns (1) a linear score that can be easily interpreted (in contrast to machine learning approaches), and (2) a weighting of the predictive power of the involved data layers, allowing for an assessment of the importance of each omic (or other) platform. Similarly to polygenic hazard score models, our methodology also allows one to compute individual survival curves for each patient.

Identifiants

pubmed: 38836403
pii: 7687754
doi: 10.1093/bib/bbae267
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Cure Alzheimer's Fund
Organisme : NIH HHS
ID : 1R01 AI 154470-01
Pays : United States
Organisme : National Science Foundation
ID : 2033046
Organisme : NIH Center
ID : P30-ES002109

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Auteurs

Georg Hahn (G)

Department of Biostatistics, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, 02115, Boston, MA, USA.

Dmitry Prokopenko (D)

Department of Neurology, Genetics and Aging Research Unit, McCance Center for Brain Health, Massachusetts General Hospital, 55 Fruit Street, 02114, Boston, MA, USA.

Julian Hecker (J)

Channing Divsion of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, 02115, Boston, MA, USA.

Sharon M Lutz (SM)

Department of Biostatistics, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, 02115, Boston, MA, USA.

Kristina Mullin (K)

Department of Neurology, Genetics and Aging Research Unit, McCance Center for Brain Health, Massachusetts General Hospital, 55 Fruit Street, 02114, Boston, MA, USA.

Leinal Sejour (L)

Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, 02215, Boston, MA, USA.

Winston Hide (W)

Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, 02215, Boston, MA, USA.

Ioannis Vlachos (I)

Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, 02215, Boston, MA, USA.

Stacia DeSantis (S)

Houston Campus, The University of Texas Health Science Center, 1200 Pressler Street, 77030, Houston, TX, USA.

Rudolph E Tanzi (RE)

Department of Neurology, Genetics and Aging Research Unit, McCance Center for Brain Health, Massachusetts General Hospital, 55 Fruit Street, 02114, Boston, MA, USA.

Christoph Lange (C)

Department of Biostatistics, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, 02115, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH